Is this a piece of news regarding world politics, sports, business, or science and technology?
Analysts See FDA Spurning New Merck Arthritis Drug Industry analysts are predicting US regulators this month will refuse to approve Merck  amp; Co. #39;s new arthritis drug until at least 2006 because of heart attacks linked to its recalled sister drug Vioxx. 
